shijiazhuang tiantian technology co.,ltd
The word is not lack of beauty but lack of decoration !!!
Add to Cart
150mg 5ml Stimulates Collagen Production PLLA Powder injection dermal fillerss dermal filler
dermal fillerss injections are a natural way to restore lost facial collagen. It contains poly-L-lactic acid, or PLLA, a substance that belongs to the alpha-hydroxy acid group. Poly-L-lactic acid is a synthetic polymer, and has been used for years in absorbable surgical sutures or stitches.
dermal fillerss functions as a facial filler either for cosmetic reasons or for medical purposes to restore and correct the signs of facial loss in patients including those diagnosed with HIV. Poly-L-lactic acid is a biocompatible and biodegradable polymer.
You can buy dermal fillerss in the form of dermal fillerss 150mg strength vials, which must be reconstituted before use by adding 5ml of sterile water for the injection, forming a sterile non-pyrogenic suspension.
How dermal fillerss Works:
The micro-particles of Poly-L-lactic acid in dermal fillerss is mixed with sterile water and then injected. It is then deposited under the skin, after which dermal fillerss breaks down and stimulates collagen production. The drug works by raising the volume of the depressed areas in the face gradually over a period of time. After 2 or 3 treatments that are separated by intervals of 4 or 6 weeks, patients will notice a natural and youthful difference in there skin.. The effects of dermal fillerss can last for as long as 2 years.
| dermal fillerss | dermal fillerss | |
| specification |
| |
| Grade |
| |
| packing |
| |
| Functions | Poly L Lactic Acid | |
| Color | white color | |
| shelf | 2 years | |
| trademark | dermal fillerss | |
| product name | dermal fillerss injection dermal fillerss butt filler dermal fillerss | |
| ingredient | plla |
There are a few precautions that need to be kept in mind when you buy dermal fillerss. These are:
* There is a risk of inflammatory reactions on the injected site if a patient undergoes any treatment that requires active dermal response after administering dermal fillerss. Examples of such treatment would include laser treatment and chemical peeling.
* The safety and efficacy of dermal fillerss has not been evaluated if it is given in large amounts in various frequencies in siteswhere signs of lipoatrophy are not present, or in sites where other dermal fillers were injected.
* The safety and efficacy of Scuptra has not been evaluated for use in the lips. Do not inject dermal fillerss into the red area, i.e.the vermillion of the lip.
* dermal fillerss is to be injected into the subcutaneous layer or the deep dermis. If it is injected superficially, it may result in side effects like papules and nodules.
* Papules and nodules may be formed if the dermal fillerss is injected in the peri-orbital area.
* dermal fillerss should not be mixed with other dermal fillers and injected into the face.
* dermal fillerss should only be administered by a medically trained professional to correct lipoatrophy in HIV patients after the professional is fully familiar with the patient's history, the product, and the entire package insert.